Company intelligence / Profile preview

OsciFlex

Philadelphia, Pennsylvania, United Statesosciflex.com ↗

Ownership: Private
Employees: ~5
Development stage: Preclinical

Overview

The company has developed a novel medical device that imitates natural blood flow patterns to prevent deadly blood clots. The approach leverages recent discoveries in the molecular pathways linking hemodynamics to endothelial gene expression relevant to thrombosis. No published clinical results yet; the company appears focused on preclinical validation and product development.

Therapeutic areas: Cardiovascular
Modalities: Medical device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on OsciFlex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OsciFlex.

Explore the full profile